Detection of recurrent pancreatic adenocarcinoma: comparison of fluorine-18-fluoro-2-deoxy-D glucose Positron Emission Tomography/Computed Tomography (PET) with contrast-enhanced Computed Tomography (ceCT) and CA19.9